Diverse facets of sphingolipid involvement in bacterial infections by Kunz, Tobias C. & Kozjak-Pavlovic, Vera
fcell-07-00203 September 17, 2019 Time: 16:43 # 1
REVIEW
published: 19 September 2019
doi: 10.3389/fcell.2019.00203
Edited by:
Burkhard Kleuser,
University of Potsdam, Germany
Reviewed by:
Rodrigo F. M. De Almeida,
University of Lisbon, Portugal
Luis M. S. Loura,
University of Coimbra, Portugal
Pedro Escoll,
Institut Pasteur, France
*Correspondence:
Vera Kozjak-Pavlovic
vera.kozjak@uni-wuerzburg.de
Specialty section:
This article was submitted to
Membrane Physiology
and Membrane Biophysics,
a section of the journal
Frontiers in Cell and Developmental
Biology
Received: 28 June 2019
Accepted: 05 September 2019
Published: 19 September 2019
Citation:
Kunz TC and Kozjak-Pavlovic V
(2019) Diverse Facets of Sphingolipid
Involvement in Bacterial Infections.
Front. Cell Dev. Biol. 7:203.
doi: 10.3389/fcell.2019.00203
Diverse Facets of Sphingolipid
Involvement in Bacterial Infections
Tobias C. Kunz and Vera Kozjak-Pavlovic*
Department of Microbiology, Biocenter, University of Würzburg, Würzburg, Germany
Sphingolipids are constituents of the cell membrane that perform various tasks as
structural elements and signaling molecules, in addition to regulating many important
cellular processes, such as apoptosis and autophagy. In recent years, it has become
increasingly clear that sphingolipids and sphingolipid signaling play a vital role in infection
processes. In many cases the attachment and uptake of pathogenic bacteria, as well
as bacterial development and survival within the host cell depend on sphingolipids.
In addition, sphingolipids can serve as antimicrobials, inhibiting bacterial growth and
formation of biofilms. This review will give an overview of our current information about
these various aspects of sphingolipid involvement in bacterial infections.
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INTRODUCTION
Sphingolipids belong to a class of lipids defined by their amino-alcohol backbone. They were
considered merely to be ubiquitous components of the eukaryotic cell membrane, shown to play a
critical role in the formation of membrane microdomains called lipid rafts that are important for
cell signaling (Simons and Ikonen, 1997). However, in the past decades, it has been revealed that
many sphingolipids are bioactive lipids that regulate a large subset of cellular functions, such as
apoptosis or autophagy (Cuvillier et al., 1996; Harvald et al., 2015). Although sphingolipids vary
greatly in their structure and function, their synthesis and degradation are mediated by common
synthetic and catabolic pathways. Sphingolipids can be synthesized de novo, by the hydrolysis
of sphingomyelin, or through the salvage pathway, by recovery of sphingosine from complex
sphingolipids (Figure 1). In all cases the result is the synthesis of ceramide, which represents the
starting point for the creation of complex sphingolipids and thus is involved in many regulating
processes within the cell. The metabolism of sphingolipids has been extensively reviewed by Gault
et al. (2010). Ceramide itself regulates growth and development and promotes cell survival and
division (Mencarelli and Martinez-Martinez, 2013).
The de novo biosynthesis of ceramide starts at the endoplasmic reticulum (ER) with an enzyme
called serine palmitoyltransferase. This enzyme catalyzes the condensation of serine and fatty
acid-CoA to 3-ketosphinganine. Afterward, 3-ketosphinganine gets reduced by 3-ketosphinganine
reductase and then is processed by dihydroceramide synthase to dihydroceramide. In the final step
of the de novo ceramide biosynthesis, a dihydroceramide desaturase introduces a double bond to
create ceramide (Perry, 2002; Menaldino et al., 2003; Figure 1).
Constitutive degradation of sphingolipids and glycosphingolipids takes place in the late
endosomes and lysosomes at acidic pH to form sphingosine (Riboni et al., 1997; Kolter and
Sandhoff, 2005). The oligosaccharide chains of glycosphingolipids are stepwise removed by the
release of monosaccharide units through exohydrolases. In the salvage pathway, long-chain
sphingoid bases are broken down to sphingosine, which is reacylated to form ceramide by an
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FIGURE 1 | Schematic representation of the sphingolipid metabolism. S1P – sphingosine-1-phosphate. The central role of the sphingolipid metabolism plays
ceramide. It is synthesized de novo from serine and palmitoyl-CoA, by hydrolysis of sphingomyelin or through the salvage pathway by recovery of sphingosine from
complex sphingolipids. Degradation of sphingolipids occurs through the degradation of S1P to hexadecenal and phosphoethanolamine by an enzyme called
S1P-lyase.
enzyme called ceramide synthase. Thus, ceramide synthase
family members probably trap free sphingosine released from
the lysosome at the surface of the ER or in ER-associated
membranes. The salvage pathway is estimated to contribute
to 50–90% of sphingolipid biosynthesis (Gillard et al., 1998;
Tettamanti et al., 2003).
During the generation of ceramide from sphingosine,
ceramide synthases add different fatty acyl chains at the
C2-amino group of the sphingosine backbone, resulting in
numerous and diverse sphingolipids. Variations in the chain
length of ceramide acyl chains are linked to potentially altered
membrane bilayer dynamics or differential signaling properties
by recruitment of different binding partners. This topic has
previously been reviewed by Grösch et al. (2012). However, the
effect of different length of acyl chains on ceramide properties and
function is poorly understood and needs further investigation.
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Ceramide exerts a specific function in mitochondria, where
the increase in ceramide has been linked to the induction
of apoptosis. Ceramide pool in mitochondria seems to be
regulated by the localized activity of ceramide synthase,
sphingomyelinases, and neutral ceramidase. However, another
source of mitochondrial ceramide could be the ER, due to
the proximity and close interaction of these two organelles
(Hernández-Corbacho et al., 2017).
Apart from ceramide, sphingosine-1-phosphate (S1P) has
been shown to be a potent signaling molecule. It is linked to the
regulation of mitochondrial function (Bajwa et al., 2015), gene
expression (Davaille et al., 2000), and ER stress (Lépine et al.,
2011). Moreover, it was implicated in the regulation of important
processes such as apoptosis, autophagy, and cell proliferation
(Harvald et al., 2015). S1P is synthesized by the sphingosine
kinase-1 and -2 (SPHK1/2) by phosphorylation of sphingosine
and degraded by the S1P phosphatase (SGPP) or lyase (SGPL1)
to sphingosine or hexadecenal and phosphoethanolamine,
respectively (Figure 1). While SPHK1 is mainly associated with
cell survival (Sarkar et al., 2005), SPHK2 has been shown to
influence mitochondrial function and homeostasis. It has also
been involved in regulation of histone deacetylases and thereby
in suppression of cell growth and promotion of apoptosis (Liu
et al., 2003). SGPP and SGPL1 ensure balanced levels of S1P
and other sphingolipid intermediates that may control cell
growth and death. The upregulation of SGPL1 results in an
accumulation of hexadecenal, which was shown to be cytotoxic
(James and Zoeller, 1997).
In the last years, sphingolipids have been revealed as key
players in infection processes. Even though most pathogenic
bacteria do not produce their own sphingolipids, they are capable
of utilizing or degrading host sphingolipids to promote their
virulence. This review will summarize some of our current
knowledge about involvement of sphingolipids in bacterial
infection, starting from the interaction with pathogenic bacteria
on the surface of the cell, including the uptake of bacteria,
immune response, survival and propagation of intracellular
bacteria, and ending with several remarks on the bactericidal
effects of sphingolipids.
BACTERIAL ENTRY - ROLE OF
SPHINGOLIPIDS IN BACTERIAL
ADHESION AND UPTAKE
Glycosphingolipids frequently serve as receptors for Escherichia
coli and other bacteria such as Pseudomonas aeruginosa,
Bordetella pertussis, Mycoplasma pneumoniae, and Helicobacter
pylori [reviewed in Hanada (2005)]. A prominent example is
GM1 ganglioside, which serves as a receptor for cholera toxin
(Holmgren et al., 1975). Also, ceramide-enriched lipid rafts
acting as binding platforms, as well as sphingolipid signaling,
such as through the activation of acid sphingomyelinase (ASM)
(Simonis and Schubert-Unkmeir, 2018), often mediate the entry
of bacterial pathogens into host cells, which is a step important
for infection and establishment of bacteria in an intracellular
niche (Figure 2).
For pathogenic Neisseria, sphingolipids play an important
role in the adhesion and invasion into the host cell. Neisseria
meningitidis, a causative agent of meningitis and meningococcal
sepsis, similar to Haemophilus influenzae binds to specific
glycosphingolipids on the host cell surface, which can be
found on human granulocytes and oropharyngeal epithelium,
the preferential habitat for these two pathogens (Hugosson
et al., 1998). Neisseria express highly variable lipooligosaccharides
(LOS) on their surface, molecular mimics of glycosphingolipids
found on human cells. LOS undergo phase variation, which is
important for immune evasion, as well as adherence and invasion
(Harvey et al., 2001).
Several reports emphasize the role of sphingomyelinases in
the invasion of pathogenic Neisseria. The activation of ASM by
N. gonorrhoeae, a bacterium causing sexually transmitted disease
gonorrhea, is important for the entry of these bacteria into non-
phagocytic cells (Grassmé et al., 1997), which occurs through
the Opa-mediated interaction of bacteria with carcinoembryonic
antigen-related cell adhesion molecule (CEACAM) receptors
(Hauck et al., 2000). Neutral sphingomyelinase (NSM) also
plays a role in the uptake of N. gonorrhoeae (Faulstich et al.,
2015), but by a different mechanism, the so-called PorBIA-
mediated low phosphate-dependent invasion (Kühlewein et al.,
2006). N. meningitidis likewise causes the activation of ASM
and ceramide release that are essential for the internalization of
meningococci into brain endothelial cells, which is connected
to the expression of the outer membrane protein OpcA and
binding to cell surface heparan sulfate proteoglycans (HSPGs)
(Simonis et al., 2014). Recently, a role of meningococcal pilus
in the translocation of ASM to the surface of infected cells has
been described (Peters et al., 2019). In all cases, invasion of
the host cell contributes to immune evasion and spreading of
these pathogenic bacteria from the site of the initial contact
to other tissues.
Uptake of bacteria through activation of sphingomyelinases
as seen for Neisseria is not always beneficial for the pathogen
but represents a host defense mechanism, as well. For example,
P. aeruginosa, associated with serious hospital-acquired
and opportunistic infections, activates host ASM, leading
to generation of plasma membrane ceramide-enriched
platforms that mediate the internalization of bacteria,
apoptosis induction and cytokine response (Grassme et al.,
2003). In macrophages, as well as in neutrophils, infection
with P. aeruginosa leads to cell death, which is important
for the clearing of infection. In both cases the role of
sphingomyelinases in this process has been proposed. For
alveolar macrophages, after the activation of the ASM upon
infection, the formation of ceramide-enriched platforms
serves to amplify ASM-mediated redox signaling, which
eventually leads to macrophage apoptosis (Zhang et al.,
2008). In the case of neutrophils, the apoptosis is mediated
through pyocyanin, a pigment and toxin released by
P. aeruginosa, and through mitochondrial ASM (Managò
et al., 2015). However, P. aeruginosa can possibly counteract
the increase in ceramide through secretion of hemolytic
phospholipase C that can synthesize sphingomyelin from
ceramide, and alkaline ceramidase, which can break down
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FIGURE 2 | Overview of the various bacterial pathogens and their interaction with sphingolipids and sphingolipid signaling pathways. ER, endoplasmic reticulum;
LCV, Legionella-containing vacuole; SCV, Salmonella-containing vacuole; SnCV, Simkania negevensis-containing vacuole; ASM, acid sphingomyelinase; NSM,
neutral sphingomyelinase; SPHK2, sphingosine kinase 2; S1P, sphingosine-1-phosphate; SMase, sphingomyelinase; CERT, ceramide transfer protein; LC3,
Microtubule-associated protein 1A/1B-light chain 3.
ceramide to avoid generation of ceramide-enriched platforms
and uptake, and increase hemolysis (Okino et al., 1998;
Okino and Ito, 2007).
Not only ceramide, but sphingosine and S1P play a part in
lung inflammatory injury caused by P. aeruginosa. SPHK2 is
phosphorylated upon P. aeruginosa infection, which increases
its nuclear localization, leading to higher levels of S1P and
increased histone acetylation. This as a consequence has an
enhanced expression of pro-inflammatory genes and secretion of
pro-inflammatory cytokines, interleukin-6, and tumor necrosis
factor-α (Ebenezer et al., 2019). Lastly, surface sphingolipids
are also involved in infection with P. aeruginosa. The bacterial
pilin binds to asialo GM1, but not to sialylated gangliosides.
Considering that the surface of epithelial cells from cystic fibrosis
patients shows differences in sialylation of glycolipids, this might
enhance susceptibility of cystic fibrosis patients to infections with
P. aeruginosa (Saiman and Prince, 1993).
Sphingolipids seem also to play a specific role in the
internalization of Mycobacteria, among which are the causative
agents of tuberculosis and leprosy, by macrophages, as
shown for Mycobacterium smegmatis. For this bacterium,
the metabolic depletion of sphingolipids in J774a.1 macrophages
led to a decrease in entry of bacteria into the host cells
(Viswanathan et al., 2018).
Finally, the pathogenicity of bacteria is often mediated
by the binding of bacterial toxins to gangliosides and
glycosphingolipids, but this aspect of the role of sphingolipids in
bacterial infections will not be reviewed here in detail. Prominent
examples are Shiga toxin from Shigella dysenteriae [reviewed in
Kavaliauskiene et al. (2017)] and Staphylococcus aureus and its
α-toxin. α-toxin has been reported to activate ASM, which leads
to changes in permeability and lung edema (Becker et al., 2017).
Ceramide increase upon S. aureus infection also stimulates
pro-inflammatory signaling through a release of cathepsin B and
D from lysosomes (Ma et al., 2017; Figure 2). Therefore, the
inflammation, edema and lung tissue damage upon S. aureus
infection seem to be induced by the binding of α-toxin and
activation of ASM.
Inhibition of sphingomyelinases as a means of controlling
inflammation and spread of infection might be consequently
beneficial for S. aureus infection (Peng et al., 2015), or infection
with pathogenic Neisseria, but is detrimental in case of infection
with P. aeruginosa (Grassme et al., 2003). It is therefore of great
importance to understand the mechanisms underlying infections
with different pathogenic bacteria, so that this knowledge could
be translated to appropriate treatments.
ONCE INSIDE - ROLE OF
SPHINGOLIPIDS IN BACTERIAL
REPRODUCTION AND SURVIVAL
Uptake of bacteria into cells can be a mechanism for bacterial
killing, through formation of phagolysosomes or induction of
autophagy. However, bacteria can avoid death by escaping into
the cytosol, preventing fusion of phagosomes and lysosomes,
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blocking autophagy, or, in some cases, surviving within the
lysosomal environment. Certain bacteria also reside in non-
lysosomal compartments inside the cell where they multiply,
avoiding recognition and immune response. Sphingolipids have
important function in many of these strategies for the survival of
pathogenic bacteria within the host cell.
Sphingolipids in Bacterial Development
and Reproduction
Obligate intracellular bacteria heavily depend on the host cell
for the procurement of the metabolites required for their
development. Sphingolipids represent important building blocks
for the membranes of compartments in which these bacteria
reside and multiply (Figure 2).
Chlamydia trachomatis, a causative agent of trachoma and
sexually transmitted disease, is characterized by a biphasic life
cycle, in which a reproductive part is spent inside the host
cell, within a vesicular compartment known as an inclusion.
Chlamydia directly obtain ceramide from the host cell Golgi and
incorporate it into the inclusion membrane (Hackstadt et al.,
1995; Figure 2). This is a process essential for the pathogen
survival, in which chlamydial inclusion fuses with trans-Golgi
network-derived secretory vesicles (van Ooij et al., 2000) in an
Akt and Rab14-mediated way (Capmany and Damiani, 2010;
Capmany et al., 2019). C. trachomatis has also been reported to
cause the fragmentation of Golgi and to induce formation of
mini stacks in the vicinity of the inclusion membrane, which
supports lipid acquisition from the host (Heuer et al., 2009).
Interestingly, it is possible that C. trachomatis establishes a
sphingomyelin biosynthetic factory at or near the inclusion with
the help of host cell proteins. Moreover, Elwell et al. (2011)
showed that C. trachomatis co-opts Golgi-specific Brefeldin
A resistance guanine nucleotide exchange factor 1 (GBF1), a
protein important for the assembly and maintenance of the
Golgi stack, for sphingomyelin acquisition contributing to the
growth and stability of the inclusion. For the replication, however,
C. trachomatis recruits ceramide transfer protein (CERT), vesicle-
associated membrane protein-associated protein A (VAP-A),
and sphingomyelin synthases, SMS1 and SMS2 to the inclusion
membrane, therewith obtaining ceramide and converting it
into sphingomyelin close to the inclusion (Elwell et al., 2011).
Recruitment of CERT occurs with the help of chlamydial effector
protein IncD present in the inclusion membrane (Agaisse and
Derre, 2014). Other reports implicate additionally the Src family
tyrosine kinase Fyn (Mital and Hackstadt, 2011), as well as
trans-Golgi SNARE protein syntaxin 6 (Moore et al., 2011) in
sphingolipid trafficking to chlamydial inclusion.
The described acquisition of sphingolipids from the host
cells seems to be a common occurrence among chlamydia.
Both Chlamydia pneumoniae and Chlamydia psittaci follow
similar mechanisms, involving exocytic vesicles or CERT protein
(Wolf and Hackstadt, 2001; Koch-Edelmann et al., 2017). In
addition, a chlamydia-like microorganism Simkania negevensis
has been likewise reported to obtain ceramide from the host
cell, a process most likely dependent on the retrograde transport
(Herweg et al., 2016).
Mycobacterium tuberculosis, although not strictly intracellular,
uses host macrophages and dendritic cells for replication.
During this process, the mycobacteria have been shown to
depend on sphingomyelin. M. tuberculosis express the protein
Rv0888, which exhibits a sphingomyelinase activity and cleaves
host sphingomyelin into ceramide and phosphorylcholine.
These compounds are used by bacteria as the sources of
carbon, nitrogen and phosphorus (Speer et al., 2015). However,
the purpose of M. tuberculosis-produced sphingomyelinases
might be not only to provide a source of nutrients, but
to modulate sphingolipid signaling and cell death induction,
thereby controlling the immune response to this pathogen
(Castro-Garza et al., 2016).
Sphingolipid Importance for the Survival
of Intracellular Bacteria
Autophagy and apoptosis play a crucial role in controlling
infection with various bacteria and viruses, representing an
important part of innate immunity, but also being manipulated
occasionally by pathogens for the purpose of survival or
replication (Rudel et al., 2010; Siqueira et al., 2018). Sphingolipids
were shown to be involved in the regulation of both apoptosis
and autophagy, with ceramide being associated with cell
death and S1P promoting cell survival (Young et al., 2013).
Increase in intracellular levels of ceramide or treatment with
sphingomyelinase has been reported to induce apoptosis in
HL-60 or U937 cells, an effect which could be prevented by
exposure of the cells to S1P (Cuvillier et al., 1996). For this,
the term “sphingolipid rheostat” has been introduced to describe
regulation of cell fate through the interconversion between
ceramide and S1P. However, a multitude of later studies has
shown a great complexity of the signaling mechanisms by which
these sphingolipid metabolites influence cell death (Newton et al.,
2015). As bacteria often modulate apoptosis to accommodate the
host cell to their own needs (Rudel et al., 2010) it is possible
that this modulation partially takes place through sphingolipid
signaling, and that mitochondrial sphingolipids play a special role
in this process. This direction is certainly worth exploring in the
future, especially for intracellular bacteria.
In addition to apoptosis, autophagy and the associated cell
death have also been subject to regulation by “sphingolipid
rheostat” (Taniguchi et al., 2012; Young et al., 2013). Autophagy is
a highly conserved catabolic process through which unnecessary
or damaged components are degraded to maintain cellular
homeostasis (Young et al., 2013; Young and Wang, 2018). In
brief: a cargo is engulfed by a membrane forming the so-
called autophagosome. Mature autophagosomes can then fuse
with lysosomes, leading to the degradation of the cargo (Miller
and Celli, 2016). It has been shown that S1P upregulates
autophagy, therefore promoting cell survival, although several
reports indicated that S1P can also act as an inhibitor of
autophagy through activation of the mammalian target of
rapamycin (mTOR) (Harvald et al., 2015). Ceramide induces
autophagy and mitophagy, could be important for fusion of
autophagosomes with lysosomes, and is involved in induction
of autophagic cell death. In addition, the “many ceramides”
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hypothesis implies that the function of ceramide depends
on the chain length, adding a level of complexity to the
regulation of autophagy through sphingolipids (Young et al.,
2013; Harvald et al., 2015). Autophagy can be further subdivided
in selective and non-selective. Non-selective autophagy describes
the degradation of a random portion of a cytosol to provide
nutrients during starvation or to degrade long-lived proteins.
Selective autophagy targets specific cellular compartments. This
includes utilizing the autophagy machinery for the removal
of mitochondria (mitophagy) or the clearance of intracellular
pathogens (xenophagy) (Deretic et al., 2013; Huang and Brumell,
2014). Hence, evading or regulating autophagy is important for
the pathogen survival.
One well-studied pathogen regulating the autophagic
machinery is Legionella pneumophila, a gram-negative bacterium
naturally replicating in protists in aquatic environments. It
is the causative agent of the Legionnaires‘ disease (Newton
et al., 2010). As many signaling pathways are conserved in
human macrophages and protists, L. pneumophila are capable
of invading human cells, where they replicate in vacuoles,
the so-called Legionella-containing vacuole (LCV). Inside
the cell, L. pneumophila secretes over 300 effector proteins
interfering with a broad range of cellular pathways. It has been
shown that many of these effector proteins have a structure
similar to eukaryotic proteins that are never or rarely found in
prokaryotic genomes. It is hypothesized that L. pneumophila
acquired these proteins through horizontal gene transfer from
its host (Cazalet et al., 2004; Gomez-Valero and Buchrieser,
2013). Among those proteins, three proteins share similarities
to eukaryotic proteins of the sphingolipid pathway: Lpp2641
(putative sphingomyelinase), Lpp2295 (putative sphingosine
kinase) and Lpp2128 or LpSPL (S1P lyase) (Rolando et al.,
2016a). The latter, being a S1P lyase, leads to the degradation
of S1P, which is a critical mediator for controlling the balance
between sphingolipid-induced autophagy and cell death.
Moreover, macrophages infected with L. pneumophila show
an overall reduction of bioactive sphingolipids. Macrophages
infected with an LpSPL mutant strain show increased levels
of sphingosine compared to wildtype L. pneumophila and
indeed, LpSPL was confirmed to restrain autophagy by acting
on autophagosome biogenesis. Thus, L. pneumophila actively
modulates sphingolipid metabolism to evade the cell autophagic
response (Rolando et al., 2016b; Figure 2).
Another pathogen indicated to manipulate autophagy via
sphingolipids is Salmonella enterica, an intestinal pathogen
that represents a major public health threat due to increasing
antibiotic resistance. Similar to Legionella, Salmonella forms
a vacuole, called the Salmonella-containing vacuole (SCV).
A recent publication extensively reviews the importance of
sphingolipids for Salmonella infection from adherence to
clearance, discussing the interaction of Salmonella, sphingolipids
and the autophagic machinery (Huang, 2017).
Salmonella has been shown to activate the focal adhesion
kinase and to recruit it to the SCV. This kinase promotes
the activation of the Akt pathway and consequently mTOR
is stimulated. This results in the suppression of autophagy
and bacterial survival (Owen et al., 2014). More recent studies
demonstrate that Salmonella does not only inhibit but actively
regulates the autophagic pathway. In the early stages of infection,
Salmonella triggers the amino acid starvation and mTOR
inhibition, resulting in the induction of autophagy (Tattoli et al.,
2012). However, in later stages the increase of cytosolic amino
acid levels in infected cells reactivates mTOR at the surface of the
SCV (Narayanan and Edelmann, 2014; Figure 2).
Inhibition of Akt signaling as well as the activation of
extracellular signal-regulated kinase (ERK) 1/2 activity is
associated with autophagy in colon adenocarcinoma cells (e.g.,
HT29 and HCT-15) (Ogier-Denis et al., 2000; Kanazawa et al.,
2004; Ellington et al., 2006). In this regard, activated ERK
was shown to upregulate beclin-1 expression, resulting in
the induction of autophagy (Liu et al., 2012). Inhibition of
the de novo biosynthesis of sphingolipids by myriocin, an
inhibitor of the enzyme serine palmitoyl transferase, leads
to decreased autophagy through the activation of Akt and
downregulation of beclin-1 (Scarlatti et al., 2004). Moreover,
myriocin downregulates ERK and represses the membrane
recruitment of NOD2 and ATG16L1. The interaction of
ATG16L1 and NOD2 in epithelial cells leads to autophagic
degradation of Salmonella. In addition, myriocin decreased the
Salmonella-induced LC3-II expression (Huang, 2016). These
findings suggest that sphingolipids may play a role in Salmonella-
induced cellular autophagy of damaged SCVs.
The cell ubiquitinates SCVs to trigger nuclear factor-
κB (NF-κB) activation, which can lead to a reduction of
bacterial propagation by the induction of inflammation.
Furthermore, Salmonella escaping to the cytosol are tagged by
a dense polyubiquitin coat (Narayanan and Edelmann, 2014).
Both ceramide and NSM2 are connected to the regulation
or modulation of protein ubiquitination and subsequent
degradation (Chapman et al., 2005; Dobierzewska et al.,
2011). Taking these facts into consideration, it is possible that
sphingolipids play a role in the ubiquitination of the SCV.
BETTER SAFE THAN SORRY -
SPHINGOLIPIDS AS ANTIMICROBIALS
Sphingolipids and sphingolipid signaling contribute to
the immune response upon bacterial infection. Acid
sphingomyelinase and ceramide play a decisive role in bacterial
internalization and inflammatory response (Li et al., 2019).
Sphingolipids, however, can also be applied as antimicrobial
substances, regulating the growth and propagation of bacteria.
Around 30 years ago Bibel and colleagues pioneered
the investigation of antimicrobial effects of sphingolipids.
They reported that sphinganine influences the growth of
N. meningitidis and Acinetobacter lwoffii and damages the
cell wall of S. aureus (Bibel et al., 1993). Moreover, they
tested sphinganine on human volunteers as a preventative
antiseptic against subsequently applied S. aureus and observed
an up to three-log reduction in the population of target
micro-organisms compared to untreated controls (Bibel et al.,
1995). Furthermore, it was shown that sphingosine effectively
killed S. aureus, Streptococcus pyogenes, Micrococcus luteus,
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Propionibacterium acnes, Staphylococcus epidermidis and
moderately killed P. aeruginosa. However, sphingosine was
demonstrated to not influence the growth of E. coli and Serratia
marcescens (Bibel et al., 1992). Although more research is needed
to understand these differences in the effect of sphingosine, one
can speculate that it might be related to the fact that E. coli and
S. marcescens are Gram-negative enterobacteria, as opposed to
the others, which are Gram-positive.
The increasing lack of antibiotic treatments due to the
development of resistances demands novel approaches for
therapies. A better understanding of the antibacterial effect of
sphingolipids may offer novel targets for treatment. Within the
last decade, the number of publications reporting antimicrobial
effects of different derivatives of sphingolipids has increased.
For instance, Banhart et al. (2014) demonstrated that
the sphingomyelin synthase inhibitor D609, which has an
effect on the uptake of fluorescently labeled ceramide by
Chlamydia muridarum (Elwell et al., 2011), reduces the
propagation of C. trachomatis. To better understand the
impact of sphingomyelin production on the growth of
C. trachomatis, they synthesized several ceramide derivatives,
such as nitrobenzooxadiazole (NBD)-labeled 1-O-methyl-
ceramide-C16. This derivative resembles to a large extent a
compound called 1-O-methyl-C6-NBD-ceramide, which has
been shown not to be converted to sphingomyelin. Interestingly,
the treatment with this newly synthetized ceramide inhibits
chlamydial growth similar to chloramphenicol and 17 times more
effectively than D609 (Banhart et al., 2014).
In another study, the antibacterial activity of sphingosine,
as well as short-chain C6 and long-chain C16-ceramides and
azido functionalized ceramide analogs was tested. The study
revealed that short-chain ceramides and a ω-azido-C6-ceramide
had antibacterial effects on N. meningitidis and N. gonorrhoeae.
The uptake of ceramides by Neisseria happened rapidly within
5 min, and the killing occurred within 2 h. In contrast to
Neisseria, these analogs did not display any effects on E. coli
and S. aureus (Becam et al., 2017). However, E. coli and
S. aureus were shown to be efficiently killed by the treatment
of dihydrosphingosine and sphingosine (Fischer et al., 2013).
During P. aeruginosa infection, lower levels of sphingosine were
observed due to a reduced activity of acid ceramidase, catalyzing
the reaction of ceramide to sphingosine. By normalization of
sphingosine levels, the susceptibility to P. aeruginosa could be
decreased (Pewzner-Jung et al., 2014). Sphingosine, sphinganine
and phytosphingosine were demonstrated to have a strong effect
on biofilm formation and adherence of Streptococcus mutans
(Cukkemane et al., 2015; Figure 2).
Beside host sphingolipids or chemically synthesized
sphingolipids, extracted sphingolipids of plants have antibacterial
activity, as well. For example, the sphingolipids ficusamide,
(S)-(−) oxypeucedanin hydrate and (R)-(+) oxypeucedanin
hydrate of Ficus exasperata showed antibacterial activity.
While ficusamide had only a low activity against E. coli,
(S)-(−) oxypeucedanin hydrate and (R)-(+) oxypeucedanin
hydrate showed significant activity against Bacillus cereus
(Dongfack et al., 2012).
CONCLUDING REMARKS
In the recent years, we have become increasingly aware of
the importance of lipids, and sphingolipids in particular, for
the processes of infection with and defense against pathogenic
bacteria. Bacterial invasion or uptake are often mediated
by bacterial attachment to glycosphingolipids or regulated
by the increase in plasma membrane ceramide. Bacterial
internalization can be a mechanism that increases pathogen
survival, but sometimes it is also a part of the immunity,
where again sphingolipids participate in the destruction
of bacteria through regulating phagosome/lysosome fusion,
apoptosis, or the inflammatory response. Intracellular bacteria
face the challenges of survival within the cell and here also
sphingolipids can be a tool to control autophagy and enable
survival, or serve as building blocks for bacterial inclusions,
ensuring their reproduction. However, sphingolipids can
be applied as antimicrobials, as well, negatively influencing
bacterial growth and biofilm formation. Understanding exact
mechanisms behind these processes remains a challenge
for the future and, in the wake of increasing antibiotic
resistance, will be of great value in our fight against
bacterial pathogens.
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